62 related articles for article (PubMed ID: 7835164)
1. Evaluation of a method for quantitative immunohistochemical analysis of cisplatin-DNA adducts in tissues from nude mice.
Johnsson A; Olsson C; Anderson H; Cavallin-Ståhl E
Cytometry; 1994 Oct; 17(2):142-50. PubMed ID: 7835164
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts.
Johnsson A; Olsson C; Nygren O; Nilsson M; Seiving B; Cavallin-Stahl E
Cancer Chemother Pharmacol; 1995; 37(1-2):23-31. PubMed ID: 7497593
[TBL] [Abstract][Full Text] [Related]
3. A topographic study on the distribution of cisplatin in xenografted tumors on nude mice.
Johnsson A; Cavallin-Stahl E
Anticancer Drugs; 1996 Jan; 7(1):70-7. PubMed ID: 8742101
[TBL] [Abstract][Full Text] [Related]
4. Expression of GADD153 in tumor cells and stromal cells from xenografted tumors in nude mice treated with cisplatin: correlations with cisplatin-DNA adducts.
Johnsson A; Strand C; Los G
Cancer Chemother Pharmacol; 1999; 43(4):348-52. PubMed ID: 10071988
[TBL] [Abstract][Full Text] [Related]
5. Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface.
Nio Y; Hirahara N; Minari Y; Iguchi C; Yamasawa K; Toga T; Tamura K
Anticancer Res; 2000; 20(5A):3293-9. PubMed ID: 11062756
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of the change in GADD153 messenger RNA level as a molecular marker of tumor response in head and neck cancer.
Los G; Benbatoul K; Gately DP; Barton R; Christen R; Robbins KT; Vicario D; Kirmani S; Orloff LA; Weisman R; Howell SB
Clin Cancer Res; 1999 Jul; 5(7):1610-8. PubMed ID: 10430059
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo.
Welters MJ; Fichtinger-Schepman AM; Baan RA; Jacobs-Bergmans AJ; Kegel A; van der Vijgh WJ; Braakhuis BJ
Br J Cancer; 1999 Jan; 79(1):82-8. PubMed ID: 10408697
[TBL] [Abstract][Full Text] [Related]
8. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system.
Light BW; Yu WD; McElwain MC; Russell DM; Trump DL; Johnson CS
Cancer Res; 1997 Sep; 57(17):3759-64. PubMed ID: 9288784
[TBL] [Abstract][Full Text] [Related]
10. Effects of intralesional injection of cisplatin on squamous cell carcinoma and normal tissue of mice.
Landrito JE; Yoshiga K; Sakurai K; Takada K
Anticancer Res; 1994; 14(1A):113-8. PubMed ID: 8166436
[TBL] [Abstract][Full Text] [Related]
11. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model.
Kamida A; Obayashi S; Kato I; Ono K; Suzuki M; Nagata K; Sakurai Y; Yura Y
Int J Radiat Biol; 2006 Jan; 82(1):21-9. PubMed ID: 16546900
[TBL] [Abstract][Full Text] [Related]
12. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
Dominguez MF; Macias RI; Izco-Basurko I; de La Fuente A; Pascual MJ; Criado JM; Monte MJ; Yajeya J; Marin JJ
J Pharmacol Exp Ther; 2001 Jun; 297(3):1106-12. PubMed ID: 11356935
[TBL] [Abstract][Full Text] [Related]
13. Hyperthermic enhancement of cis-diamminedichloroplatinum (II)-induced DNA damage in human esophageal cancer transplantable to nude mice.
Yano T; Nakatani K; Nakano H; Ihara M; Ohnishi T
Anticancer Res; 1993; 13(6A):1989-97. PubMed ID: 8297105
[TBL] [Abstract][Full Text] [Related]
14. In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenografts.
Song K; Cowan KH; Sinha BK
Oncol Res; 1999; 11(3):153-9. PubMed ID: 10527075
[TBL] [Abstract][Full Text] [Related]
15. [Circadian rhythms of DNA synthesis and apoptosis correlated gene expression in bone marrow cells of nude mice bearing human nasopharyngeal carcinoma].
Sun J; Xian LJ; Cao QY; Ye YL; Zeng ZL; Liu XH; Li XM; Levi F
Ai Zheng; 2002 Aug; 21(8):833-7. PubMed ID: 12478887
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of platinated DNA in the cochlea of cisplatin-treated guinea pigs.
van Ruijven MW; de Groot JC; Hendriksen F; Smoorenburg GF
Hear Res; 2005 May; 203(1-2):112-21. PubMed ID: 15855036
[TBL] [Abstract][Full Text] [Related]
17. Glycerol enhances CDDP-induced growth inhibition of thyroid anaplastic carcinoma tumor carrying mutated p53 gene.
Yuki K; Takahashi A; Ota I; Ohnishi K; Yasumoto J; Kanata H; Yane K; Hosoi H; Ohnishi T
Oncol Rep; 2004 Apr; 11(4):821-4. PubMed ID: 15010879
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of combination chemotherapy with 5-FU and CDDP for human gastric carcinoma transplanted into nude mice].
Yamada T; Tanase M; Watanabe A; Sawada H; Yamada Y; Shino Y; Yamashita J; Matsuda M; Nakano H
Gan To Kagaku Ryoho; 1997 Jan; 24(1):43-7. PubMed ID: 9020944
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
